Health - Google News: Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe - Forbes

Health - Google News Google News

Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe - Forbes Sep 21st 2012, 14:08 TIME Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe Forbes Vivus stock slumped more than 10% this morning after the company said its weight-loss drug will likely be denied approval in Europe. The European Medicines Agency will make a formal decision on the drug, Qsiva, at a meeting next month. Vivus Shares Drop 11% On News That European Regulators May Reject Qsiva MAANASDAQ Europe May Reject Vivus' Obesity Drug, Shares DropInvestorplace.com Vivus: European Committee Could Recommend Against Weight-Loss DrugWall Street Journal Barron's (blog) -Proactive Investors USA & Canada -Reuters all 111 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: